For the quarter ended September 30, 2026, Acadia Healthcare reported revenue of $895.3 million, a 5.1% increase over the prior year. Net income attributable to the company was $34.5 million, down slightly from $36.2 million in 2025, while the company significantly improved its operating cash flow to $321.5 million for the first nine months of the year.
Acadia Healthcare reported Q3 2026 revenue of $895.3 million, a 5.1% increase year-over-year, driven by strong performance in acute inpatient psychiatric facilities. While net income slightly decreased to $34.5 million, the company raised its full-year 2026 financial guidance based on positive operational momentum and facility expansions.
Term
Q3 2026
“Acadia delivered strong results in the third quarter, and our positive momentum is driving our increased full-year guidance. We remain focused on our key priorities, including expanding access to quality patient care and consistent operational execution with financial discipline.”
The U.S. District Court for the Middle District of Tennessee granted preliminary approval for a settlement of several consolidated stockholder derivative actions against Acadia Healthcare and certain individual defendants. The litigation, which includes cases in both Tennessee and Delaware, alleged breaches of fiduciary duty and securities law violations related to matters previously disclosed in 2025. The settlement aims to fully resolve and discharge all released claims nominally asserted on behalf of the company.